Global Procurement Specialist
Current•Ensures > 300 million CHF spent on materials and plant reservation fees is converted to revenue•Leads introductory calls with new suppliers and negotiates confidentiality and supply agreements to protect Roche's growing Cell and Gene Therapy pipeline•Published step by step guidance on the Medical Device group's contracting process so contracts and POs can be tracked effectively in the future leading to less discrepancies and increased clarity in regards to amount spent